Skip to content

DrugPatentWatch - Transform Data into Market Domination

Blog Home
DrugPatentWatch Home
Plans & Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Blog Home
DrugPatentWatch Home
Plans & Pricing
About
Contact

Table 1. Content statistics of MCD and TCD, populated from journal papers and patents, respectively

Leave a Comment / By DrugPatentWatch / November 26, 2017

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

Differences in rates of switchbacks after switching…
Tracking 20 Years of Compound-to-Target Output from…
Measuring the knowledge translation and convergence…
Contribution of NIH funding to new drug approvals 2010–2016
CDCDB: A large and continuously updated drug…
A Review about Regulatory Status and Recent Patents…
The Biosimilar Landscape: An Overview of Regulatory…
Review of Drugs Approved via the 505(b)(2) Pathway:…
A Comparison of Generic Drug Prices in Seven…
A Comprehensive Map of FDA-Approved Pharmaceutical Products
A comprehensive review of database resources in chemistry
Is Patent “Evergreening” Restricting Access to…
Market access of gene therapies across Europe, USA,…
Drug Spending in the US: Where the Money Actually Goes
Development of Generic Drug Products by…
Using Google Patents for Drug Patent Research: A…
Development of the generic drug industry in the US…
Drug repurposing patent documents vs peer review:…
Artificial intelligence in drug discovery: what is…
Ideation and implementation of an open science drug…
When should you outsource drug development
Managing Drug Patent Litigation Costs
Affordability and availability of off-patent drugs…
The basics of patent searching

Post navigation

Tracking 20 Years of Compound-to-Target Output from Literature and Patents

Get Email Updates

Email

Upcoming Drug Patent Expirations

Make Better Decisions

See Plans & Pricing

Recent Posts

Drafting Effective Drug Patent Applications: Turning Science into Market Power
Decoding Drug Pricing Models: A Strategic Guide to Market Domination
Patient-Centric Approaches to Maintaining Brand Value
AI-Based Drug Repurposing for Neurological Disorders: Current Status
Regulatory considerations for biosimilar extrapolation of indications

Popular Posts

The Role of China in the Global Generic Drug API Market
Sourcing the Key Starting Materials (KSMs) for pharmaceutical Active Pharmaceutical Ingredients (APIs)
Drug Patent Life: The Complete Guide to Pharmaceutical Patent Duration and Market Exclusivity
Handling Drug Patent Invalidity Claims
Valuation of Pharma Companies: 5 Key Considerations
Decoding Drug Pricing Models: A Strategic Guide to Market Domination
Top 6 issues facing the biotechnology industry
Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements
Patient-Centric Approaches to Maintaining Brand Value
Valuation of Pharmaceutical Companies: A Comprehensive Analysis of Key Considerations

Copyright © 2025 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested